INDIVIOR ANNOUNCES CHANGES TO BOARD OF DIRECTORS

Company

Indivior Pharmaceuticals, Inc.

Filed

December 17, 2024

Period of Report

December 17, 2024

Accession Number

0001654954-24-015644